Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
18.07
+0.21 (1.18%)
At close: Dec 20, 2024, 4:00 PM
17.90
-0.17 (-0.94%)
After-hours: Dec 20, 2024, 4:02 PM EST

Rapport Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Market Capitalization
661--
Enterprise Value
342--
Debt / Equity Ratio
0.010.050.53
Quick Ratio
45.1716.7518.74
Current Ratio
45.9117.1418.80
Return on Equity (ROE)
--43.36%-
Return on Assets (ROA)
--24.18%-
Return on Capital (ROIC)
--25.52%-
Buyback Yield / Dilution
-1491.15%-93.74%-
Total Shareholder Return
-1491.15%-93.74%-
Source: S&P Capital IQ. Standard template. Financial Sources.